Engagement & Excellence Council

Dr. Ben Clyburn is a nationally recognized leader in graduate medical education and clinical teaching, currently serving as Professor and Chair of the Department of Medicine. In his role as chairman, Dr. Clyburn oversees the clinical, education, and research programs of the department, which consists of 10 divisions and is the largest at the MUSC College of Medicine.

A faculty member since 1997, Dr. Clyburn has played a transformative role in shaping internal medicine education at MUSC for over two decades.

During his career at MUSC, Dr. Clyburn has held numerous leadership roles, including Program Director for the Internal Medicine Residency; Secretary, Vice President, and President of the Medical Staff; Associate Dean for GME-Faculty Development; Vice Chair for Graduate Medical Education; Senior Associate Dean for GME and CME; and Designated Institutional Official (DIO) for GME. He was appointed Chair of the Department of Medicine in 2021 after serving as Interim Chair in 2020.

He has served on the Nonprescription Drugs Advisory Committee for the U.S. FDA and served eight years on the ACGME Review Committee for Internal Medicine. Dr. Clyburn is a Fellow of the American College of Physicians and an engaged member of national organizations such as SGIM and APDIM. He currently holds the Boyle Endowed Chair in General Internal Medicine, supporting his continued work in education and geriatric care.

A respected mentor and educator, Dr. Clyburn has received multiple awards including the Golden Apple Award, the Michael E. Assey Award for Outstanding Teaching, and ongoing recognition in Best Doctors in America.

A graduate of MUSC (M.D., 1989), Dr. Clyburn completed his internal medicine residency and chief residency at Wake Forest before holding faculty and leadership roles at the University of Texas Medical Branch University of Texas, Galveston prior to joining MUSC.

I am a lung cancer pulmonologist with expertise in the evaluation, management, and improvement of outcomes of patients with lung cancer. I conduct patient-oriented clinical research studies that encompass nearly every aspect of lung cancer care, including lung cancer screening, disparities in cancer care, shared decision-making, and the evaluation and management of pulmonary nodules. I have a graduate degree in the evaluative clinical sciences, and I apply the health services research techniques I learned to many aspects of lung cancer care.

General Internal Medicine

Medical School: Louisiana State University Health Sciences Center Shreveport Shreveport, LA
Residency: Internal Medicine and Pediatrics, University of Mississippi Medical Center

General Internal Medicine (Palliative Care) 

Dr. Craig Lockhart is the Director of the Division of Hematology & Oncology at MUSC and Associate Director for Clinical Science at MUSC Hollings Cancer Center. His research specialty is gastrointestinal cancers, and he has been a principal investigator on more than 100 Phase I/II and III trials.

Prior to joining MUSC, Dr. Lockhart was on the faculty and in leadership roles at the University of Miami, Miller School of Medicine, Washington University in St. Louis/Siteman Cancer Center, and at Vanderbilt University/Vanderbilt-Ingram Cancer Center.

Dr. Lockhart has been conducting early-phase clinical trials for over 20 years. His specific research interests are developing and conducting Phase I/II clinical trials of novel therapeutics applied to gastrointestinal cancers. In treating these cancers, he aims to incorporate novel agents or molecular/genetic-based treatments into therapeutic trials in the pursuit of personalized cancer care. He has developed and led multi-institutional clinical trials involving the treatment of GI tumors through national cooperative groups as well as investigator-initiated studies. He has been an investigator and co-investigator on individual grants, on successful SPORE grant applications and on successful multi-institutional UM1 grant applications.

Dr. Lockhart has also served on several committees for the American Society of Clinical Oncology (ASCO), including the scientific and career development committees. He has been a member of the National Comprehensive Cancer Network (NCCN) guidelines committee for gastric and esophageal cancers. He also serves as faculty at the ASCO/American Association for Cancer Research (AACR) Methods in Clinical Cancer Research Workshop, mentoring fellows and junior faculty on the development of gastrointestinal cancer therapeutic protocols.

Dr. Lockhart graduated from the University of Texas Southwestern Medical School at Dallas in 1993. He completed residency training at Barnes Hospital at Washington University, fellowship training in hematology/oncology at Duke University and a fellowship in drug development at GlaxoSmithKline in the North Carolina Research Triangle Park. He also earned a Master of Health Science degree in clinical trials at Duke University. He completed his undergraduate degree, a bachelor’s in biology, at Rice University.

Hospital Medicine

Medical School: George Washington University School of Medicine and Health Sciences, Washington, DC
Residency: Internal Medicine, University of Maryland Medical Center, Baltimore, MD; Chief Resident
Fellowship: Clinical Fellowship Transplant/Immunocompromised Host, Emory University
Additional degree: Masters of Science in Clinical Research, Emory University
Clinical and Research Interests: HIV/AIDS Medicine and Transplant/Immunocompromised States

Professor

Pulmonary Critical Care

Pulmonary Critical Care

Rheumatology